
Diorasis Therapeutics Appoints Dr. Dimitri Azar to Board
Diorasis Therapeutics, a biotechnology company pioneering durable gene therapies for glaucoma and other ophthalmic diseases, today announced the appointment of Dimitri Azar, MD, MBA, AM (hon.), DHL (hon.), to its Board of Directors. Dr. Azar is a globally recognized leader…








